Research RARE SUBTYPES
POSTERS AND PUBLICATIONS
THE LATEST ON UVEAL MELANOMA RESEARCH AND CLINICAL TRIALS: “Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting” published in Clinical Cancer Research in January 2021.
“Uveal Melanoma Patient Attitudes Towards Prognostic Testing Using Gene Expression Profiling” poster presented at the Association for Research in Vision and Ophthalmology (ARVO). The poster presented data from more than 200 responses to a patient survey sponsored by CURE OM and Castle Biosciences.
2011 CURE OM founded by OM patient Dr. Gregg Stracks and his wife, Dr. Sara Selig.
CURE OM has awarded over $2.1 million in ocular melanoma research funding and launched the historic global patient-reported VISION Registry.
2021
TIMELINE
6
Made with FlippingBook Ebook Creator